Rajkumar SV - Search Results

1

MRK003, a γ-secretase inhibitor exhibits promising in vitro pre-clinical activity in multiple myeloma and non-Hodgkin's lymphoma.

Ramakrishnan V, Ansell S, Haug J, Grote D, Kimlinger T, Stenson M, Timm M, Wellik L, Halling T, Rajkumar SV, Kumar S. Ramakrishnan V, et al. Among authors: rajkumar sv. Leukemia. 2012 Feb;26(2):340-8. doi: 10.1038/leu.2011.192. Epub 2011 Aug 9. Leukemia. 2012. PMID: 21826062 Free PMC article.

2

Bone marrow angiogenesis in patients achieving complete response after stem cell transplantation for multiple myeloma.

Rajkumar SV, Fonseca R, Witzig TE, Gertz MA, Greipp PR. Rajkumar SV, et al. Leukemia. 1999 Mar;13(3):469-72. doi: 10.1038/sj.leu.2401336. Leukemia. 1999. PMID: 10086738

3

Clinical significance of the translocation (11;14)(q13;q32) in multiple myeloma.

Fonseca R, Hoyer JD, Aguayo P, Jalal SM, Ahmann GJ, Rajkumar SV, Witzig TE, Lacy MQ, Dispenzieri A, Gertz MA, Kyle RA, Greipp PR. Fonseca R, et al. Among authors: rajkumar sv. Leuk Lymphoma. 1999 Nov;35(5-6):599-605. doi: 10.1080/10428199909169625. Leuk Lymphoma. 1999. PMID: 10609798

4

Thalidomide for previously untreated indolent or smoldering multiple myeloma.

Rajkumar SV, Dispenzieri A, Fonseca R, Lacy MQ, Geyer S, Lust JA, Kyle RA, Greipp PR, Gertz MA, Witzig TE. Rajkumar SV, et al. Leukemia. 2001 Aug;15(8):1274-6. doi: 10.1038/sj.leu.2402183. Leukemia. 2001. PMID: 11480571 Clinical Trial.

5

Thalidomide in the treatment of multiple myeloma.

Rajkumar SV. Rajkumar SV. Expert Rev Anticancer Ther. 2001 Jun;1(1):20-8. doi: 10.1586/14737140.1.1.20. Expert Rev Anticancer Ther. 2001. PMID: 12113124 Review.

6

Thalidomide as an anti-cancer agent.

Kumar S, Witzig TE, Rajkumar SV. Kumar S, et al. Among authors: rajkumar sv. J Cell Mol Med. 2002 Apr-Jun;6(2):160-74. doi: 10.1111/j.1582-4934.2002.tb00184.x. J Cell Mol Med. 2002. PMID: 12169202 Free PMC article. Review.

7

Chromosome abnormalities clustering and its implications for pathogenesis and prognosis in myeloma.

Debes-Marun CS, Dewald GW, Bryant S, Picken E, Santana-Dávila R, González-Paz N, Winkler JM, Kyle RA, Gertz MA, Witzig TE, Dispenzieri A, Lacy MQ, Rajkumar SV, Lust JA, Greipp PR, Fonseca R. Debes-Marun CS, et al. Among authors: rajkumar sv. Leukemia. 2003 Feb;17(2):427-36. doi: 10.1038/sj.leu.2402797. Leukemia. 2003. PMID: 12592343

8

Thalidomide as initial therapy for early-stage myeloma.

Rajkumar SV, Gertz MA, Lacy MQ, Dispenzieri A, Fonseca R, Geyer SM, Iturria N, Kumar S, Lust JA, Kyle RA, Greipp PR, Witzig TE. Rajkumar SV, et al. Leukemia. 2003 Apr;17(4):775-9. doi: 10.1038/sj.leu.2402866. Leukemia. 2003. PMID: 12682636 Clinical Trial.

9

Expression of VEGF and its receptors by myeloma cells.

Kumar S, Witzig TE, Timm M, Haug J, Wellik L, Fonseca R, Greipp PR, Rajkumar SV. Kumar S, et al. Among authors: rajkumar sv. Leukemia. 2003 Oct;17(10):2025-31. doi: 10.1038/sj.leu.2403084. Leukemia. 2003. PMID: 14513053

10

Effect of allogeneic stem cell transplantation on bone marrow angiogenesis in chronic myelogenous leukemia.

Kumar S, Litzow MR, Rajkumar SV. Kumar S, et al. Among authors: rajkumar sv. Bone Marrow Transplant. 2003 Dec;32(11):1065-9. doi: 10.1038/sj.bmt.1704260. Bone Marrow Transplant. 2003. PMID: 14625577

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

822 results

Search Page

Filters